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Prevalence, Treatment, and Control of Hypertension by
Sociodemographic Factors Among the Dutch Elderly
Caroline T.M. van Rossum, Hendrike van de Mheen, Jacqueline C.M. Witteman, Albert Hofman,
Johan P. Mackenbach, Diederick E. Grobbee
Abstract—The study objective was to assess the prevalence, level of treatment, and control of hypertension in a general
elderly population according to age and sociodemographic factors. We conducted a cross-sectional analysis of 7983
participants of the Rotterdam Study who were $55 years old and living in a district of Rotterdam. The prevalence of
hypertension was based on blood pressure levels ($160/95 mm Hg) and the use of blood pressure–lowering medication
for the indication of hypertension, type of treatment, and control of hypertension. Systolic blood pressure rises with age,
whereas diastolic blood pressure declines. The prevalence of hypertension increases with age and was higher among
women (39%) than among men (31%). About 80% of the hypertensives were aware of having hypertension, and 82%
of the 80% were treated. For 70% of them, treatment was adequate with reference to conservative criteria. Hypertension
was more prevalent among persons not living in a home for the elderly, for more-educated men, and for less-educated
women. Persons without a partner and men living in a home for the elderly had a higher risk of being unaware of or
of not being treated for existing hypertension. Treatment was more often successful among those living in a home for
the elderly. The prevalence of hypertension was higher among older women and increased with age in both genders. A
large proportion of hypertensive elderly persons were aware and were successfully treated for hypertension. The degree
of awareness and control appeared to be affected by sociodemographic factors. More importantly, the majority of
hypertensives did not have their hypertension well controlled. This group requires more attention by medical
practitioners to reduce the burden of cardiovascular diseases in elderly persons. (Hypertension. 2000;35:814-821.)
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Hypertension is an important risk factor for cardiovascu-lar diseases. One of the cornerstones of the primary
prevention of cardiovascular diseases has been screening for
high blood pressure and antihypertensive drug treatment.1
Until recently, elderly subjects were excluded from treatment
studies, despite the fact that they are at high risk for
complications or death from hypertension-related diseases.2
However, the benefits of antihypertensive drug therapy for
older persons have been clearly established.3–8 Results from
trials and meta-analyses have shown that antihypertensive
drug treatment for older hypertensive persons confers highly
significant and clinically relevant reductions in cardiovascu-
lar morbidity and mortality rates.2,8 Nevertheless, a consider-
able percentage of older persons with hypertension are not
detected or are not adequately treated for hypertension.
We provide data on the prevalence, treatment, awareness,
and control of hypertension among an elderly Dutch popula-
tion. In addition, we examined whether there are socioeco-
nomic and demographic differences in the diagnosis and
treatment of hypertension.
Methods
Study Population
The present study was conducted as a part of the Rotterdam Study,
a prospective cohort study among 7983 persons (response rate 78%)
$55 years old and living in 1 defined geographic area in Rotterdam,
the Netherlands. The rationale and design of the study have been
described elsewhere.9 In summary, the objective of the Rotterdam
Study was to investigate the determinants of chronic and disabling
cardiovascular, neurogeriatric, locomotor, and ophthalmologic dis-
eases. The baseline examination started in 1990 and continued until
June 1993. The examinations consisted of a home visit by trained
interviewers and 2 follow-up visits for a clinical examination at the
research center. The study was approved by the Medical Ethics
Committee of Erasmus University, and written informed consent was
obtained from all participants.
Measurements
Blood Pressure
On 1 occasion, systolic and diastolic blood pressures from the right
upper arm were measured with a random-zero sphygmomanometer
twice with the patient in a sitting position. The mean of the 2 blood
pressure readings was used to determine blood pressure levels.
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Hypertension was defined as a systolic blood pressure of
$160 mm Hg, a diastolic blood pressure of $95 mm Hg, the current
use of blood pressure–lowering drugs for the indication of hyperten-
sion, or a combination. The use of medication and type of medication
were assessed during the home interview by a research assistant. The
participants subsequently showed all their currently used medication
at the research center, where a physician determined the indication
for which each medication had been prescribed. In case of blood
pressure levels below the cutoff points and inconsistencies or
missing values regarding indication, additional information was used
to classify subjects as hypertensive or nonhypertensive. This addi-
tional information was obtained, first, from the response to the
question, “Have you ever been told by a doctor that you have
hypertension?” and, second, from the response to the question,
“Were you ever treated with drugs because of high blood pressure?”
On the basis of their awareness, treatment status, and control of
hypertension, hypertensives were classified into 4 subgroups: treated
and controlled, treated and uncontrolled, untreated and aware, and
untreated and unaware. In the hypertensives who were treated, a
distinction was made between those for whom blood pressure was
,160/95 mm Hg and thus controlled (“treated and controlled”) and
those for whom blood pressure was not controlled (“treated and
uncontrolled”). Information on awareness was obtained on the basis
of the response to the question, “Have you ever been told by a doctor
that you have hypertension?” By definition, those who were treated
were considered to be aware of having hypertension. Blood pres-
sure–lowering drugs were classified into 3 categories: diuretics,
b-blockers, and “other” antihypertensive medication.
Sociodemographic Factors
Information on education, occupation (eg, professionals, routine
non–manual workers, small business owners, and manual workers),
and household income (in quartiles) as indicators of socioeconomic
status was obtained by trained interviewers during the home visit at
the study baseline (1990 to 1993). Similar results were observed for
the associations of hypertension with these different indicators. We
report here the results for the indicator “education” only, because the
number of missing values (4%) for this indicator was the lowest. The
participants were asked about their formal education, the number of
years of each type of education, and whether education had been
completed. From this information, the highest attained level of
education was defined, and this was classified into 3 categories: low
(eg, primary education), medium (eg, lower-level general education,
intermediate-level general education, and lower-level vocational
education), and high (eg, higher-level general education,
intermediate-level vocational education, higher-level vocational ed-
ucation, and university). The other sociodemographic factors (ie,
“having a partner,” health insurance status, and living situation) were
assessed during the same interview with a questionnaire. On the
basis of the question regarding partnership, subjects were catego-
rized into 2 groups: those currently with a partner and those without
a partner, including widowed and divorced persons. Health insurance
was dichotomized into health insurance via the Sickness Fund (for
persons below a certain income level) and private insurance (for
persons above this income level and civil servants). Living situation
was divided into living independently and living in a home for
the elderly.
Data Analysis
All analyses were performed with the SPSS package and were
performed separately for women and men. The prevalence of
hypertension was assessed on the basis of 5-year age groups.
These age-specific prevalence rates were weighted according to
the age distribution in the Netherlands in 1992 to estimate the
prevalence of hypertension for the total Dutch elderly population.
Frequencies of awareness, treatment, or control were assessed on the
basis of 10-year age groups. Mean blood pressure levels according to
10-year age groups and by subgroups of hypertensives were calcu-
lated with regression analysis. In addition, regression analyses in
which age was included as an ordinal variable (1, 2, 3, and 4) were
performed to test for trend.
Multivariate linear and logistic regression analyses were per-
formed to determine the age-adjusted association between several
sociodemographic factors and blood pressure levels, prevalence of
hypertension, being unaware of having hypertension compared with
being aware, being untreated compared with being treated, and
having uncontrolled compared with having controlled hypertension.
In addition, the relationship between these factors and the use of a
certain type of medication was assessed with multivariate logistic
regression analysis.
Results
Distributions of age and sociodemographic variables for the
study population are shown in Table 1. The mean age of the
women was slightly higher than that of the men (72 [SD 9]
and 69 [SD 10] years, respectively). Forty percent of the
population had attended only primary school. Generally, men
had higher education levels than women; 15% of the men and
4% of the women were classified in the highest educational
groups. Educational level was inversely associated with age.
Of subjects younger than 65, 13% were classified in the
highest educational group versus 6% of subjects older than
65. The majority (84% of the men and 51% of the women)
had a partner, and the proportion of widowed or divorced
women was higher than the proportion of widowed or
divorced men (results not shown). Furthermore, relatively
more women were institutionalized than men. Finally, rela-
tively more men than women had private insurance.
Prevalence of Hypertension
Figure 1 shows the increasing prevalence of hypertension
with age for men and women. The overall prevalence of
hypertension, standardized to the total Dutch population, was
higher in women than in men (39% and 31%, respectively).
For the women, the prevalence of hypertension continuously
increased with age, from 22% in the youngest age group to
52% in those $85 years old. For men, the prevalence rate
increased with age until 80 years (from 22% to 39%).
Awareness, Treatment, and Control
of Hypertension
Figure 2 shows the levels of awareness, treatment, and
control of hypertension for male and female hypertensives by
age. In total, 25% of the hypertensive men and 18% of the
hypertensive women were not aware of having hypertension.
Of those aware of having hypertension, ’82% were treated.
Furthermore, 70% of those treated were normotensive with
treatment. Of all hypertensives, only 46% had controlled
hypertension. For both genders, this proportion of controlled
hypertensives decreased with age, whereas the proportion of
treated uncontrolled hypertensives increased with age. For
men, the proportion of persons aware of having hypertension
(treated and untreated) also decreased with age.
Blood Pressure
Table 2 shows the mean systolic and diastolic blood pressure
values for the total population and for subgroups classified by
awareness and treatment status. In general, systolic blood
pressure increased and diastolic blood pressure decreased
with age. Women showed a stronger increase in systolic
blood pressure with age than did men. The decrease in
diastolic blood pressure with age was more marked among
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men than among women. Despite these differences between
men and women, mean systolic and diastolic blood pressures
did not considerably differ between men and women. The
mean systolic and diastolic blood pressures of controlled
hypertensives were slightly higher than those of the
normotensives.
Antihypertensive Drug Treatment
Table 3 shows the proportions of the various blood pressure–
lowering drugs used by men and women in monotherapy or
combination therapy. Diuretics were more often prescribed
for older patients and for women. Furthermore, the use of
b-blockers decreased with age. Other antihypertensive drugs,
TABLE 1. Characteristics of Study Population
Characteristic
Men
(n53105)
Women
(n54878)
Age, %
55–59 y 16.5 14.7
60–64 y 20.9 17.2
65–69 y 21.1 15.6
70–74 y 16.8 15.7
75–79 y 12.5 13.2
80–84 y 7.4 10.6
$85 y 4.9 12.9
Education, % (n53017) (n54552)
High: intermediate/higher general education,
intermediate/higher vocational education, and
university
49.6 23.2
Medium: lower general and lower vocational education 22.5 28.5
Low: primary education 27.9 48.3
With a partner, % (n52662) (n54375)
With a partner 83.7 50.8
Without a partner (including widowed and divorced
persons)
16.3 49.2
Living situation, %
Living independently 94.0 85.4
Living in a home for the elderly 6.0 14.6
Health insurance, %
Private insurance 51.9 36.8
Sickness fund 48.1 63.5
Figure 1. Prevalence of hypertension by
age and gender. Hypertension was
defined as a systolic blood pressure of
$160 mm Hg, a diastolic blood pressure
of $95 mm Hg, or current use of blood
pressure–lowering drugs for indication of
hypertension.
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such as calcium channel antagonists, were mainly prescribed
for male hypertensives aged 65 to 74 years and female
hypertensives aged 75 to 84 years. The proportion of patients
using other antihypertensive drugs was higher in men than in
women.
Note that blood pressure–lowering drugs are also pre-
scribed for indications other than hypertension (for the
normotensives as well as for the hypertensives); for example,
almost 13% of the normotensives were using blood pressure–
lowering drugs for an indication other than hypertension.
Differences by Socioeconomic and
Demographic Factors
Table 4 shows the age-adjusted odds ratios for hypertension
and for being unaware, untreated, or uncontrolled according
to several sociodemographic factors. Hypertension was
slightly more frequent among the more-educated men, less-
educated women, and those not living in a home for the
elderly. A higher systolic blood pressure was observed among
those not living in a home for the elderly (12 and 6 mm Hg
for women and men, respectively).
Among male hypertensives, less-educated men, those liv-
ing in a home for the elderly, and those without a partner
tended to be less aware of having hypertension. Among
female hypertensives, no clear sociodemographic differences
in awareness were observed.
For those aware of having hypertension, men and women
without a partner, men with private health insurance, and men
living in a home for the elderly were less often treated.
Finally, a lower proportion of treated persons living indepen-
dently had controlled hypertension compared with those
living in a home for the elderly.
The type of treatment also differed by these sociodemo-
graphic factors. b-Blockers were less often prescribed for the
less-educated persons, those with insurance via the Sickness
Fund, men with a partner, and women without a partner
(results not shown). Diuretics were less often prescribed for
the less-educated women and women without a partner.
Finally, other antihypertensive agents were more often pre-
scribed for women without a partner and those living in a
home for the elderly (results not shown).
Figure 2. Distribution of hypertension
across categories of unawareness, treat-
ment, and control by age and gender. As
a result of missing data, awareness,
treatment, and control classifications
could not be made for 224
hypertensives.
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Discussion
This study provides data on the prevalence, treatment, aware-
ness, and control of hypertension among an elderly Dutch
population. Furthermore, data are given on sociodemographic
differences in the diagnosis, treatment, and control of hyper-
tension. To appreciate the findings, certain methodological
aspects of the study should be considered.
First, the potential of selective participation must be
addressed. Despite a high response rate, it is likely that our
study population is relatively healthy compared with the total
Dutch population, because older persons and those with
health problems are less likely to participate.10,11 Conse-
quently, the true prevalence rate of hypertension in Dutch
persons $55 years old may be somewhat higher. In addition,
our study population includes relatively more older persons
than the total Dutch population in these age groups. This
latter problem was solved with calculation of the total
prevalence rate of hypertension on the basis of age-weighted
prevalence rates.
Blood pressure was measured twice at 1 visit; this may lead
to an overestimation of the prevalence of hypertension and to
an underestimation of adequately controlled patients among
those treated with antihypertensive medication.12 For this
reason, we used a definition of hypertension based on rather
conservative blood pressure levels and the use of blood
pressure–lowering medication. The relatively high blood
pressure criteria limit the potential of misclassification of a
diagnosis of hypertension because blood pressure levels were
TABLE 2. Mean Systolic and Diastolic Blood Pressures According to Age and Gender in Total Population and Across Categories of
Awareness, Treatment, and Control of Hypertension
Gender/Age Category
Total Population Normotensives
Participants With Actual Hypertension
Untreated,
Unaware
Untreated,
Aware
Treated,
Uncontrolled
Treated,
Controlled
n SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP
Men, aged 551 y 2797 138.7 74.5 130.8 71.4 171.1 84.5 170.8 89.6 175.6 87.0 135.8 74.4
55–64 y 1095 134.7 76.1 128.3 73.2 170.1 91.1 171.1 91.4 172.8 91.1 135.1 77.2
65–74 y 1074 140.4 74.5 132.5 71.1 170.9 86.2 169.8 88.5 175.6 86.3 135.6 74.2
75–84 y 518 142.3 71.5 132.5 68.2 171.9 79.9 175.0 86.9 179.4 83.4 137.7 69.4
851 y 110 145.1 72.9 134.0 69.4 * * * * * * * *
P trend ,0.001 ,0.001 ,0.001 ,0.001 0.50 ,0.001 0.46 0.078 0.008 0.003 0.26 ,0.001
Women, aged 551 y 4212 139.9 73.1 130.0 69.7 170.9 83.0 172.7 85.5 173.6 83.4 137.5 73.1
55–64 y 1470 130.8 73.5 124.4 70.8 168.6 86.8 168.4 88.0 167.8 89.3 134.4 76.3
65–74 y 1392 142.1 73.5 132.9 69.8 171.2 83.4 171.5 85.7 171.9 84.5 139.8 73.5
75–84 y 953 147.8 72.7 135.8 68.3 172.4 79.8 175.5 85.2 176.6 82.2 138.6 70.5
851 y 396 147.2 71.1 134.9 66.4 170.3 83.7 177.6 81.0 175.6 77.1 135.2 66.3
P trend ,0.001 ,0.001 ,0.001 ,0.001 0.32 0.035 ,0.001 0.006 ,0.001 ,0.001 0.053 ,0.001
SBP indicates systolic blood pressure; DBP, diastolic blood pressure. Values are given in mm Hg.
*The number in this group is ,25, and therefore no mean is given.
TABLE 3. Use of Various Antihypertensive Agents for Men and Women
Gender/Age Category n (100%) Diuretics, % b-Blockers, %
Other Antihypertensive
Agents, %
Male treated hypertensives 576 32.7* 51.5 52.5
55–64 y 195 23.1 52.3 51.8
65–74 y 251 30.8 52.0 57.2
75–84 y 117 49.6 50.4 45.3
Male normotensives† 1867 4.9 6.5 5.4
Female treated hypertensives 1191 52.9 45.0 39.1
55–64 y 291 42.1 52.1 32.1
65–74 y 417 48.2 50.6 37.6
75–84 y 362 61.3 39.0 45.0
851 y 121 70.3 27.3 43.0
Female normotensives† 2521 7.5 4.1 3.4
*Diuretics, b-blockers, and other antihypertensive agents are prescribed in monotherapy as well as in combination
therapy. Therefore, the sum of the proportion of users of diuretics, the proportion of users of b-blockers, and the
proportion of users of other antihypertensive agents exceeds 100%.
†Use of these medications for indications other than hypertension.
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based on measurements obtained at a single occasion. The
definition of normotension includes subjects with borderline
isolated systolic hypertension to such an extent that systolic
blood pressure was between 140 and 160 mm Hg. This
applied to 20% of the men and women. A comparison of the
prevalence of hypertension with that of other studies should
be done with caution because of different cutoff points,
number of measurements, or different measurement tech-
niques.13,14 For example, if we had chosen lower cutoff points
of blood pressure levels (eg, 140/90 mm Hg) instead of
160/95 mm Hg, the prevalence rates of hypertension would
have been 52% and 58% for men and women, respectively. In
our study, we did not include in the prevalence estimates
persons with a normal blood pressure who are using blood
pressure–lowering drugs for other indications than hyperten-
sion. Results from this study indicate that blood pressure–
lowering drugs are frequently used for other indications,
especially in an older population. In several other reports,
however, users of blood pressure–lowering drugs were not
specified by indication.
The classification of hypertensives into “untreated and
unaware,” “untreated and aware,” and “treated and uncon-
trolled” categories may be affected by the differences in
cognitive performance in this elderly population. Persons
with cognitive decline could be misclassified, because they
are likely to have had more problems with answering the
questions. Furthermore, it is likely that cognitive decline with
age is more prevalent among those with a lower socioeco-
nomic status,15 among older persons, and possibly even in
those with clinically elevated blood pressure levels. The
direction in which this misclassification has affected the
results is unclear.
To classify socioeconomic status in this study, we used the
indicator “education.” Each indicator (eg, education, occupa-
tion, and income) represents another dimension of socioeco-
nomic status. However, there is some overlap among the
main indicators of socioeconomic status. This is confirmed by
our findings (not shown) that other available indicators of
socioeconomic status (eg, income and occupational level) in
general showed the same trends.
The results of this study demonstrate that hypertension is
more prevalent among elderly women than among men and
that the prevalence increases with age. Although a compari-
son with other studies is difficult due to the problems
mentioned earlier, our results do not substantially differ from
those obtained from a recent overview of studies on the
prevalence of hypertension in the Netherlands.13 Other stud-
ies among elderly subjects have similarly shown a higher
prevalence of hypertension among women compared with
men and an increase with age.6,14,16–18 Hormonal factors,
postmenopausal weight gain, and a different risk profile
might account for the higher age-specific prevalence rates of
hypertension among women compared with men.16 Diastolic
blood pressure levels off with age,17,19 and at older ages
systolic blood pressure rises, resulting in a higher prevalence
of isolated systolic blood pressure.16 Possibly, the decline in
diastolic blood pressure reflects increased atherosclerosis in
this aging population due to stiffening of the large arteries.20
Several studies have demonstrated a beneficial effect of
treatment in older persons. Trials of patients older than 60
years have shown that antihypertensive drug therapy reduces
the risk of stroke, cardiovascular diseases, heart failure, and
death.3–7,21 Nevertheless, several studies, including ours, have
shown that a considerable proportion of the hypertensives are
TABLE 4. Sociodemographic Factors and Hypertension, Being Unaware of Having Hypertension, Being Untreated, or Uncontrolled
(odds ratios adjusted for age)
Sociodemographic Factor
Total Population Hypertensives Aware Hypertensives
Treated
Hypertensives
Hypertension Unaware* Untreated† Uncontrolled‡
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Men
Education
Medium (vs high) 0.90 0.73–1.10 1.29 0.86–1.92 0.74 0.42–1.39 1.22 0.76–1.95
Low (vs high) 0.85 0.70–1.03 1.26 0.86–1.85 0.83 0.50–1.39 0.90 0.56–1.45
Having no partner (vs having a partner) 1.11 0.87–1.43 1.45 0.93–2.27 2.89 1.65–5.08 0.96 0.50–1.86
Health insurance via Sickness Fund (vs private insurance) 0.93 0.78–1.09 1.13 0.82–1.56 0.59 0.38–0.90 0.92 0.62–1.35
Living in a home for the elderly (vs living independently) 0.84 0.57–1.22 1.49 0.78–2.85 2.51 0.96–6.57 0.36 0.13–1.55
Women
Education
Medium (vs high) 1.17 0.98–1.40 1.01 0.68–1.50 0.90 0.59–1.37 0.87 0.58–1.31
Low (vs high) 1.20 1.01–1.42 0.92 0.64–1.32 0.89 0.61–1.32 1.12 0.77–1.63
Having no partner (vs having a partner) 0.94 0.81–1.09 0.97 0.71–1.32 1.39 0.99–1.95 0.87 0.64–1.20
Health insurance via Sickness Fund (vs private insurance) 0.99 0.87–1.13 1.09 0.82–1.44 1.03 0.76–1.40 0.89 0.67–1.18
Living in a home for the elderly (vs living independently) 0.53 0.42–0.67 1.07 0.68–1.68 1.05 0.58–1.89 0.40 0.24–0.66
*Risk for being Untreated Unaware for all hypertensives.
†Risk for being Untreated Aware for all aware hypertensives (Treated Controlled, Treated Uncontrolled, and Untreated Aware).
‡Risk for being Treated Uncontrolled for all treated hypertensives.
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not aware of having hypertension and that among those who
are aware, a considerable proportion are not treated.17,22–26
The frequencies of awareness, however, appear to vary
substantially, ranging from 23% in China to 97% in women in
the United States.25 The percentage of aware of hypertensives
in our study population, about 75%, is lower than that
reported from most industrialized countries.17 Similar to most
other studies, the women in our population have a better
awareness than men.23,25 This finding suggests that general
practitioners make different monitoring and treatment deci-
sions according to gender or that health consciousness differs
between genders.
In our male study population, unawareness of hypertension
tended to increase with age. Several explanations for this
increase with age can be considered. First, it is likely that
physicians are still more hesitant to diagnose hypertension in
elderly persons due to a lack of consensus on the cutoff points
for hypertension and a possible awareness of white coat
hypertension among elderly persons.27 Second, it is possible
that the physician-patient communication differs with age.
Third, cognitive function of the participants may have af-
fected the awareness.
Approximately 66% of the hypertensives in our study
population were treated, and for a majority of those (70%),
this treatment was adequate with reference to our conserva-
tive criteria. A comparison of this proportion with the “rules
of halves,” which has been the dogma of the past (ie, only half
of the hypertensives are detected, half of which are treated, of
which only half achieve adequate blood pressure control), and
other recent surveys among the elderly,19,28 suggests that
there is an increasing tendency for medical treatment among
the elderly and a better quality of control. However, a
considerable proportion of the hypertensives are not treated
or are treated ineffectively, especially at older ages. Indeed, in
view of the recent data from the Hypertension Optimal
Treatment (HOT) study, only 30% of the treated hyperten-
sives in our study population reached the rather low targets
defined in this trial. However, the public health impact of
even a small decline can be substantial.
Until now, no single drug class is regarded as uniquely
suitable as the first-line therapy for all elderly patients. For
example, Messerli et al29 reported poor impact of the use of
b-blockers on blood pressure levels and the prevention of
cardiovascular diseases exclusive of stroke in older hyperten-
sives.29 Therefore, it is not possible to judge whether the
persons are treated in an optimal way. The most appropriate
choice of antihypertensive drug often depends on compara-
tive adverse profiles, the presence of comorbidity,12 and the
use of other medication.30 This might explain why treatment
strategies differ according to gender and age. For example,
diuretics were more often prescribed for patients at older ages
and for women, and b-blockers were less often prescribed for
patients at older ages. In addition, our study showed that these
medications are also frequently prescribed for other
indications.
Several studies have reported an inverse association be-
tween socioeconomic status and hypertension or blood pres-
sure level.31,32 Our findings among women are consistent
with these studies. The positive association observed among
men, however, is in contrast to these studies and is also in
contrast to recent studies conducted in the Netherlands among
younger persons.33 Nevertheless, the results in men are in
line with Dutch studies carried out some decades ago.34,35
Hoeymans et al33 reported a change in the association
between socioeconomic status and hypertension with time in
the Netherlands. Our findings suggest, however, that this
change may not occur within a generation but rather across
the generations.
Our finding that health insurance status affects the treat-
ment of male hypertensives suggests either that Dutch phy-
sicians distinguish between the type of insurance held by a
patient or that men with private insurance use medical care in
a different way compared with those without private insur-
ance. Especially among men, “having a partner” may have a
beneficial effect on the awareness and treatment of hyperten-
sion.36 Explanations for these associations with partnership
require further investigation.
For 54% of the hypertensives, blood pressure levels were
not controlled. To achieve a better control of hypertension
among elderly persons, more attention should be given to the
detection and subsequent treatment and control of hyperten-
sion. Subgroups of persons who require special care are men
without a partner and men living in a home for the elderly.
In conclusion, the prevalence rate of hypertension is higher
among older women and increases with age for both genders.
A substantial proportion of hypertensive elderly persons are
aware of and successfully treated for hypertension. However,
a still considerable proportion of persons, which increases
with age, do not have their hypertension well controlled.
These hypertensives require more attention by medical prac-
titioners to reduce the burden of cardiovascular diseases in
the elderly.
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